View Older Stories View More Recent Stories

May 6, 2025 04:05PM Protagonist Reports First Quarter 2025 Financial Results and Provides Corporate Update
Apr 11, 2025 06:37AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Apr 11, 2025 05:15AM BTIG Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 11, 2025 09:02AM Protagonist Therapeutics (PTGX) PT Raised to $72 at BMO Capital Post ANTHEM/ICONIC Data
Mar 10, 2025 02:16PM Jefferies Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 10, 2025 09:34AM Protagonist Therapeutics (PTGX) PT Raised to $76 at Truist Securities
Mar 10, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 10, 2025 05:12AM BTIG Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 10, 2025 04:28AM Citizens JMP Reiterates Market Outperform Rating on Protagonist Therapeutics (PTGX)
Mar 4, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 3, 2025 02:34PM Protagonist Therapeutics (PTGX) PT Raised to $73 at BTIG
Mar 3, 2025 01:28PM Truist Securities Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 3, 2025 01:21PM TD Cowen Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 3, 2025 11:52AM Protagonist Therapeutics (PTGX) PT Raised to $57 at JPMorgan
Mar 3, 2025 06:46AM Protagonist Therapeutics (PTGX) and Takeda (TAK) Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Feb 28, 2025 08:44AM JPMorgan Reiterates Overweight Rating on Protagonist Therapeutics (PTGX)
Feb 24, 2025 07:10AM Protagonist Therapeutics (PTGX) PT Raised to $54 at H.C. Wainwright
Feb 21, 2025 07:00AM Protagonist Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Feb 19, 2025 04:41AM Citizens JMP Reiterates Market Outperform Rating on Protagonist Therapeutics (PTGX)
Feb 7, 2025 09:47AM Truist Reiterates Buy Rating on Protagonist Therapeutics (PTGX) Following KOL Feedback
Feb 7, 2025 04:37AM JMP Securities Reiterates Market Outperform Rating on Protagonist Therapeutics (PTGX)
Jan 23, 2025 05:06AM Jefferies Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Jan 6, 2025 04:05PM Protagonist Therapeutics Reports Granting of Inducement Awards
Dec 12, 2024 01:16PM Clear Street Starts Protagonist Therapeutics (PTGX) at Buy, Top Pick
Dec 10, 2024 08:51AM BTIG Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Dec 5, 2024 04:10PM BMO Capital Starts Protagonist Therapeutics (PTGX) at Outperform
Nov 22, 2024 02:07PM Truist Securities Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Nov 22, 2024 05:21AM Protagonist Therapeutics (PTGX) PT Raised to $67 at BTIG
Nov 19, 2024 06:55AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Nov 8, 2024 06:36AM Protagonist Therapeutics (PTGX) Tops Q3 EPS by 4c
Nov 7, 2024 04:05PM Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Oct 14, 2024 08:06AM TD Cowen Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Sep 24, 2024 05:35AM TD Cowen Starts Protagonist Therapeutics (PTGX) at Buy
Sep 12, 2024 07:29AM Protagonist Therapeutics (PTGX) PT Raised to $50 at H.C. Wainwright
Sep 9, 2024 06:06AM Truist Securities Starts Protagonist Therapeutics (PTGX) at Buy
Sep 3, 2024 07:30AM Protagonist Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
Aug 7, 2024 06:49AM Protagonist Therapeutics (PTGX) PT Raised to $40 at H.C. Wainwright
Aug 6, 2024 07:42AM Protagonist Therapeutics (PTGX) Tops Q2 EPS by 10c
Aug 6, 2024 07:00AM Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Jul 31, 2024 09:19AM Protagonist Therapeutics (PTGX) Appoints Newman Yeilding as Chief Scientific Advisor
Jul 31, 2024 09:15AM Protagonist Announces Appointment of Newman Yeilding, M.D. as Chief Scientific Advisor
Jul 24, 2024 04:56AM Protagonist Therapeutics (PTGX) PT Raised to $51 at BTIG
Jul 22, 2024 07:00AM Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024
Jul 1, 2024 05:00PM These are BTIG's top pick stocks for H2 2024
Jun 27, 2024 05:18PM Protagonist Therapeutics (PTGX) to Join S&P SmallCap 600
Jun 17, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Jun 11, 2024 04:10PM Protagonist Therapeutics (PTGX) PT Raised to $39 at JPMorgan
View More Recent Stories View Older Stories